Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ADIR's new MMP and TNF-alpha production inhibitors described in recent patent

Jan. 31, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

NYU School of Medicine and P&U establish anticancer drug discovery collaboration

Jan. 31, 2000

Oxford BioMedica and IDM to collaborate on cell-based therapies

Jan. 31, 2000

Two new anticancer human MAbs enter development at AVI BioPharma

Jan. 28, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Licensing opportunity from NIH: 5-lipoxygenase inhibitors as anticancer agents

Jan. 28, 2000

Novel CDK4 inhibitor series available for licensing from NIH

Jan. 27, 2000

Dendreon initiates patient enrollment in phase III prostate cancer study

Jan. 27, 2000

Eisai team identifies promising new selective RARalpha agonist

Jan. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...